Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00060008" target="_blank" >RIV/00023001:_____/16:00060008 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.termedia.pl/Hepatology-topics-of-special-interest-from-Central-Europe-Czech-Republic-Hungary-Poland-Slovakia-,80,27221,1,1.html" target="_blank" >http://www.termedia.pl/Hepatology-topics-of-special-interest-from-Central-Europe-Czech-Republic-Hungary-Poland-Slovakia-,80,27221,1,1.html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/ceh.2016.58852" target="_blank" >10.5114/ceh.2016.58852</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)
Popis výsledku v původním jazyce
This compilation represents abstracts of presentations at the first meeting of the Initiative Group for the Central European Hepatologic Collaboration (CEHC, Warsaw, 19-21 November, 2015) on topics with special interest from four Central European countries and includes a summary of a boceprevir-based triple therapy cohort programme (from Hungary), current trends and challenges in liver diseases (from Poland), acute kidney injury in liver cirrhosis (from Slovakia) and treatment of hepatitis C in haemodialysed patients (from the Czech Republic). All these topics are or have been of high interest during the last several years, and many of them are still not completely resolved with the emergence and availability of the novel interferon-free therapies for hepatitis C and with other advances in the pathophysiology and treatment of liver diseases.
Název v anglickém jazyce
Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)
Popis výsledku anglicky
This compilation represents abstracts of presentations at the first meeting of the Initiative Group for the Central European Hepatologic Collaboration (CEHC, Warsaw, 19-21 November, 2015) on topics with special interest from four Central European countries and includes a summary of a boceprevir-based triple therapy cohort programme (from Hungary), current trends and challenges in liver diseases (from Poland), acute kidney injury in liver cirrhosis (from Slovakia) and treatment of hepatitis C in haemodialysed patients (from the Czech Republic). All these topics are or have been of high interest during the last several years, and many of them are still not completely resolved with the emergence and availability of the novel interferon-free therapies for hepatitis C and with other advances in the pathophysiology and treatment of liver diseases.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FE - Ostatní obory vnitřního lékařství
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Clinical and experimental hepatology
ISSN
2392-1099
e-ISSN
—
Svazek periodika
2
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
PL - Polská republika
Počet stran výsledku
5
Strana od-do
16-20
Kód UT WoS článku
000382013300005
EID výsledku v databázi Scopus
—